Pharmacoepidemiology and Drug SafetyVolume 21, Issue 8 p. 900-901 Commentary Reply to the commentary by Onuigbo on the article “Exposure to inhibitors of the renin–angiotensin system is a major independent risk factor for acute renal failure induced by sucrose-containing intravenous immunoglobulins. A case–control study” Guillaume Moulis, Corresponding Author Guillaume Moulis Laboratoire de Pharmacologie Médicale et Clinique, Centre Midi-Pyrénées de PharmacoVigilance, de Pharmacoépidémiologie et d'Informations sur le Médicament, CHU Toulouse, Toulouse, France Service de Médecine Interne, CHU Toulouse, Toulouse, France UMR1027 INSERM-Université de Toulouse III, Toulouse, France Université de Toulouse, Faculté de Médecine, Toulouse, FranceG. Moulis, Service de Pharmacologie Clinique, Faculté de Médecine, 37 Allées Jules-Guesde, 31000 Toulouse. E-mail: [email protected]Search for more papers by this authorLaurent Sailler, Laurent Sailler Service de Médecine Interne, CHU Toulouse, Toulouse, France UMR1027 INSERM-Université de Toulouse III, Toulouse, France Université de Toulouse, Faculté de Médecine, Toulouse, FranceSearch for more papers by this authorJean-Louis Montastruc, Jean-Louis Montastruc Laboratoire de Pharmacologie Médicale et Clinique, Centre Midi-Pyrénées de PharmacoVigilance, de Pharmacoépidémiologie et d'Informations sur le Médicament, CHU Toulouse, Toulouse, France UMR1027 INSERM-Université de Toulouse III, Toulouse, France Université de Toulouse, Faculté de Médecine, Toulouse, FranceSearch for more papers by this author Guillaume Moulis, Corresponding Author Guillaume Moulis Laboratoire de Pharmacologie Médicale et Clinique, Centre Midi-Pyrénées de PharmacoVigilance, de Pharmacoépidémiologie et d'Informations sur le Médicament, CHU Toulouse, Toulouse, France Service de Médecine Interne, CHU Toulouse, Toulouse, France UMR1027 INSERM-Université de Toulouse III, Toulouse, France Université de Toulouse, Faculté de Médecine, Toulouse, FranceG. Moulis, Service de Pharmacologie Clinique, Faculté de Médecine, 37 Allées Jules-Guesde, 31000 Toulouse. E-mail: [email protected]Search for more papers by this authorLaurent Sailler, Laurent Sailler Service de Médecine Interne, CHU Toulouse, Toulouse, France UMR1027 INSERM-Université de Toulouse III, Toulouse, France Université de Toulouse, Faculté de Médecine, Toulouse, FranceSearch for more papers by this authorJean-Louis Montastruc, Jean-Louis Montastruc Laboratoire de Pharmacologie Médicale et Clinique, Centre Midi-Pyrénées de PharmacoVigilance, de Pharmacoépidémiologie et d'Informations sur le Médicament, CHU Toulouse, Toulouse, France UMR1027 INSERM-Université de Toulouse III, Toulouse, France Université de Toulouse, Faculté de Médecine, Toulouse, FranceSearch for more papers by this author First published: 14 June 2012 https://doi.org/10.1002/pds.3302Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. Volume21, Issue8August 2012Pages 900-901 RelatedInformation